| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 72.284 | 62.634 | 44.899 | 46.109 | 40.674 | 36.884 | 30.743 | 35.415 | 39.594 | 44.321 |
| Total Income - EUR | 72.312 | 62.692 | 44.971 | 46.204 | 40.687 | 36.884 | 30.901 | 35.415 | 39.594 | 44.321 |
| Total Expenses - EUR | 66.349 | 54.170 | 40.229 | 42.015 | 38.013 | 33.475 | 29.078 | 31.265 | 35.536 | 40.533 |
| Gross Profit/Loss - EUR | 5.964 | 8.521 | 4.742 | 4.190 | 2.674 | 3.409 | 1.823 | 4.149 | 4.058 | 3.788 |
| Net Profit/Loss - EUR | 5.009 | 6.639 | 3.392 | 2.799 | 1.461 | 2.561 | 896 | 3.139 | 3.487 | 3.254 |
| Employees | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Lucvital Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.156 |
| Current Assets | 31.240 | 30.874 | 39.120 | 50.758 | 52.827 | 49.184 | 49.526 | 49.670 | 46.836 | 44.458 |
| Inventories | 29.840 | 28.401 | 36.583 | 49.945 | 52.005 | 48.408 | 49.246 | 48.909 | 45.372 | 42.825 |
| Receivables | 1.164 | 1.182 | 2.482 | 782 | 615 | 549 | 0 | 0 | 0 | 4 |
| Cash | 237 | 1.290 | 55 | 31 | 208 | 226 | 280 | 760 | 1.464 | 1.629 |
| Shareholders Funds | 6.631 | 13.202 | 16.371 | 18.869 | 19.965 | 22.147 | 22.553 | 25.762 | 29.170 | 32.261 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 24.610 | 17.672 | 22.749 | 31.889 | 32.862 | 27.037 | 26.973 | 23.908 | 17.666 | 13.353 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4776 - 4776" | |||||||||
| CAEN Financial Year |
4776
|
|||||||||
Comments - Lucvital Bio S.r.l.